IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

254
IARC MONOGRAPHS VOLUME 82
Denissenko, M.F., Cahill, J., Koudriakova, T.B., Gerber, N. & Pfeifer, G.P. (1999) Quantitation
and mapping of aflatoxin B 1-induced DNA damage in genomic DNA using aflatoxin B 1-8,9epoxide
and microsomal activation systems. Mutat. Res., 425, 205–211
Denning, D.W. (1987) Aflatoxin and human disease. Adv. Drug React. Ac. Pois. Rev., 6, 175–209
Denning, D.W., Allen, R., Wilkinson, A.P. & Morgan, M.R. (1990) Transplacental transfer of aflatoxin
in humans. Carcinogenesis, 11, 1033–1035
Denning, D.W., Quiepo, S.C., Altman, D.G., Makarananda, K., Neal, G.E., Camallere, E.L.,
Morgan, M.R.A. & Tupasi, T.E. (1995) Aflatoxin and outcome from acute lower respiratory
infection in children in The Philippines. Ann. trop. Paediatr., 15, 209–216
De Vries, H.R., Maxwell, S.M. & Hendrickse, R.G. (1989) Foetal and neonatal exposure to aflatoxins.
Acta paediatr. scand., 78, 373–378
Donnelly, P.J. & Massey, T.E. (1999) Ki-ras activation in lung cells isolated from AC3F1 (A/J x
C3H/HeJ) mice after treatment with aflatoxin B 1. Mol. Carcinog., 26, 62–67
Donnelly, P.J., Stewart, R.K., Ali, S.L., Conlan, A.A., Reid, K.R., Petsikas, D. & Massey, T.E.
(1996) Biotransformation of aflatoxin B 1 in human lung. Carcinogenesis, 17, 2487–2494
Dorner, J.W., Cole, R.J. & Diener, U.L. (1984) The relationship of Aspergillus flavus and
Aspergillus parasiticus with reference to production of aflatoxins and cyclopiazonic acid.
Mycopathologia, 87, 13–15
Dragacci, S. & Frémy, J.M. (1993) [Milk contamination by aflatoxin M 1: Results of 15 years of
surveillance]. Sci. Alim., 13, 711–722 (in French)
Duflot, A., Hollstein, M., Mehrotra, R., Trepo, C., Montesano, R. & Cova, L. (1994) Absence of
p53 mutation at codon 249 in duck hepatocellular carcinomas from the high incidence area
of Qidong (China). Carcinogenesis, 15, 1353–1357
Dycaico, M.J., Stuart, G.R., Tobal, G.M., de Boer, J.G., Glickman, B.W. & Provost, G.S. (1996)
Species-specific differences in hepatic mutant frequency and mutational spectrum among
lambda/lacI transgenic rats and mice following exposure to aflatoxin B 1. Carcinogenesis, 17,
2347–2356
Eaton, D.L. & Gallagher, E.P. (1994) Mechanisms of aflatoxin carcinogenesis. Annu. Rev.
Pharmacol. Toxicol., 34, 135–172
Eaton, D.L. & Groopman, J.D., eds (1994) The Toxicology of Aflatoxins: Human Health,
Veterinary, and Agricultural Significance, San Diego, CA, Academic Press
Edrington, T.S., Harvey, R.B. & Kubena, L.F. (1995) Toxic effects of aflatoxin B 1 and ochratoxin
A, alone and in combination, on chicken embryos. Bull. environ. Contam. Toxicol., 54,
331–336
Egner, P.A., Wang, J.-B., Zhu, Y.-R., Zhang, B.-C., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-
Y., Gange, S.J., Jacobson, L.P., Helzlsouer, K.J., Bailey, G.S., Groopman, J.D. & Kensler,
T.W. (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high
risk for liver cancer. Proc. natl Acad. Sci. USA, 98, 14601–14606
El-Nezami, H.S., Nicoletti, G., Neal, G.E., Donohue, D.C. & Ahokas, J.T. (1995) Aflatoxin M 1 in
human breast milk samples from Victoria, Australia and Thailand. Food chem. Toxicol., 33,
173–179
EN (European Norm) (1999a) Milk and Milk Powder — Determination of Aflatoxin M 1 Content —
Cleanup by Immunoaffinity Chromatography and Determination by High-performance
Liquid Chromatography (EN ISO 14504), Brussels, European Committee for Standardization